Bringing together researchers from Italy and the US, Chroma Medicine has emerged out of stealth with series A financing led by Cormorant Asset Management.

GV and ADM Ventures Investments Corp contributed to the online farming community and services provider's series G round at a $3.9bn valuation.

Nationwide Ventures participated in a round for the Medicare brokerage made up of $35m in equity financing and a $100m credit facility.

The device management platform developer closed its third round in two years with backing from Okta Ventures.

Autonomous driving technology developer MaxiEye bagged nearly $50m in a Desay-led round while software testing technology producer Mabl raised $40m from investors including GV and Presidio Ventures.

Cancer research software provider Owkin received the funding as part of a strategic collaboration partnership which will involve it working with Sanofi on potential treatments.

Subsidiaries of Alphabet and Cisco were among the investors which pushed the cybersecurity technology provider to unicorn status.

Schlumberger New Energy co-led a round for the water treatment specialist sized at over $100m, hiking its overall funding to more than $200m.

Labcorp backed a debt and equity round for the cancer diagnostics technology developer as it advances its screening platform torwards commercialisation.

ANZ Bank's 1835i affiliate backed the $100m second tranche of a round that lifted the payment technology provider’s total funding past $800m.